Tapewire

Nasdaq · USD

BLFS

BIOLIFE SOLUTIONS INC

Export transactions ↓
Tapewire entity
4614
SEC CIK
0000834365
Parsed reports
1,001

Last 12 months

Inside the activity.

0 purchase rows · 39 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 2025014
Dec 202508
Jan 202605
Feb 202600
Mar 202609
Apr 202600
May 202603
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 08, 2021 Filed Feb 20, 2021 01:00 UTC
Berard ToddChief Marketing Officer
GrantRestricted Stock Award · Derivative 3,610 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001437749-21-003513 · rdgdoc.xml · derivative · entry 6

Berard Todd · CIK 0001633186 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,610

Underlying: Common Stock · 3,610 shares

Expires not disclosed

F4 · shares: The restricted stock was granted pursuant to the Plan. The restricted stock will vest as to between 0% and 200% of the reported number of shares in column 5 based on the registrant's total shareholder return during the period beginning on January 1, 2021 through December 31, 2022 as compared to the total shareholder return of certain of the registrant's peers (such peers have been determined by the registrant's compensation committee with assistance of an outside consultant immediately prior to the grant date) and will vest on the date on which the registrant's board of directors determine the total shareholder return for the period.

F4 · derivative.exercise_date: The restricted stock was granted pursuant to the Plan. The restricted stock will vest as to between 0% and 200% of the reported number of shares in column 5 based on the registrant's total shareholder return during the period beginning on January 1, 2021 through December 31, 2022 as compared to the total shareholder return of certain of the registrant's peers (such peers have been determined by the registrant's compensation committee with assistance of an outside consultant immediately prior to the grant date) and will vest on the date on which the registrant's board of directors determine the total shareholder return for the period.

F4 · derivative.expiration_date: The restricted stock was granted pursuant to the Plan. The restricted stock will vest as to between 0% and 200% of the reported number of shares in column 5 based on the registrant's total shareholder return during the period beginning on January 1, 2021 through December 31, 2022 as compared to the total shareholder return of certain of the registrant's peers (such peers have been determined by the registrant's compensation committee with assistance of an outside consultant immediately prior to the grant date) and will vest on the date on which the registrant's board of directors determine the total shareholder return for the period.

Read SEC document
February 08, 2021 Filed Feb 20, 2021 01:00 UTC
Berard ToddChief Marketing Officer
Exercise / conversionCommon Stock 12,982 Not disclosed Not disclosed
Disclosure

SEC source: 0001437749-21-003513 · rdgdoc.xml · nonDerivative · entry 2

Berard Todd · CIK 0001633186 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,470

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: The reporting person was granted restricted stock pursuant to the Plan on February 25, 2019. In accordance with the terms of the grant, the restricted stock vested as to 200% of the reported number of shares reported in the reporting person's Form 4 reporting the grant based on the registrant's total shareholder return during the period beginning on January 1, 2019 through December 31, 2020 as compared to the total shareholder return of 20 of the registrant's peers (such peers have been determined by the registrant's compensation committee with assistance of an outside consultant immediately prior to the grant date).

F2 · price: The reporting person was granted restricted stock pursuant to the Plan on February 25, 2019. In accordance with the terms of the grant, the restricted stock vested as to 200% of the reported number of shares reported in the reporting person's Form 4 reporting the grant based on the registrant's total shareholder return during the period beginning on January 1, 2019 through December 31, 2020 as compared to the total shareholder return of 20 of the registrant's peers (such peers have been determined by the registrant's compensation committee with assistance of an outside consultant immediately prior to the grant date).

Read SEC document
February 08, 2021 Filed Feb 20, 2021 01:00 UTC
Berard ToddChief Marketing Officer
GrantCommon Stock 3,610 Not disclosed Not disclosed
Disclosure

SEC source: 0001437749-21-003513 · rdgdoc.xml · nonDerivative · entry 1

Berard Todd · CIK 0001633186 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,488

F1 · price: The restricted stock was granted pursuant to the BioLife Solutions 2013 Performance Incentive Plan (the "Plan") and vests 25% on the first anniversary of the grant date and thereafter quarterly, in 12 equal quarterly installments. The restricted stock was granted to the reporting person as part of 2021 compensation.

Read SEC document
February 08, 2021 Filed Feb 20, 2021 01:00 UTC GrantRestricted Stock Award · Derivative 4,740 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001437749-21-003512 · rdgdoc.xml · derivative · entry 6

DE GREEF RODERICK · CIK 0001241181 · CFO & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,740

Underlying: Common Stock · 4,740 shares

Expires not disclosed

F4 · shares: The restricted stock was granted pursuant to the Plan. The restricted stock will vest as to between 0% and 200% of the reported number of shares in column 5 based on the registrant's total shareholder return during the period beginning on January 1, 2021 through December 31, 2022 as compared to the total shareholder return of certain of the registrant's peers (such peers have been determined by the registrant's compensation committee with assistance of an outside consultant immediately prior to the grant date) and will vest on the date on which the registrant's board of directors determine the total shareholder return for the period.

F4 · derivative.exercise_date: The restricted stock was granted pursuant to the Plan. The restricted stock will vest as to between 0% and 200% of the reported number of shares in column 5 based on the registrant's total shareholder return during the period beginning on January 1, 2021 through December 31, 2022 as compared to the total shareholder return of certain of the registrant's peers (such peers have been determined by the registrant's compensation committee with assistance of an outside consultant immediately prior to the grant date) and will vest on the date on which the registrant's board of directors determine the total shareholder return for the period.

F4 · derivative.expiration_date: The restricted stock was granted pursuant to the Plan. The restricted stock will vest as to between 0% and 200% of the reported number of shares in column 5 based on the registrant's total shareholder return during the period beginning on January 1, 2021 through December 31, 2022 as compared to the total shareholder return of certain of the registrant's peers (such peers have been determined by the registrant's compensation committee with assistance of an outside consultant immediately prior to the grant date) and will vest on the date on which the registrant's board of directors determine the total shareholder return for the period.

Read SEC document
February 08, 2021 Filed Feb 20, 2021 01:00 UTC Exercise / conversionCommon Stock 31,552 Not disclosed Not disclosed
Disclosure

SEC source: 0001437749-21-003512 · rdgdoc.xml · nonDerivative · entry 2

DE GREEF RODERICK · CIK 0001241181 · CFO & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 192,585

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: The reporting person was granted restricted stock pursuant to the Plan on February 25, 2019. In accordance with the terms of the grant, the restricted stock vested as to 200% of the reported number of shares reported in the reporting person's Form 4 reporting the grant based on the registrant's total shareholder return during the period beginning on January 1, 2019 through December 31, 2020 as compared to the total shareholder return of 20 of the registrant's peers (such peers have been determined by the registrant's compensation committee with assistance of an outside consultant immediately prior to the grant date).

F2 · price: The reporting person was granted restricted stock pursuant to the Plan on February 25, 2019. In accordance with the terms of the grant, the restricted stock vested as to 200% of the reported number of shares reported in the reporting person's Form 4 reporting the grant based on the registrant's total shareholder return during the period beginning on January 1, 2019 through December 31, 2020 as compared to the total shareholder return of 20 of the registrant's peers (such peers have been determined by the registrant's compensation committee with assistance of an outside consultant immediately prior to the grant date).

Read SEC document
February 08, 2021 Filed Feb 20, 2021 01:00 UTC GrantCommon Stock 4,740 Not disclosed Not disclosed
Disclosure

SEC source: 0001437749-21-003512 · rdgdoc.xml · nonDerivative · entry 1

DE GREEF RODERICK · CIK 0001241181 · CFO & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 161,033

F1 · price: The restricted stock was granted pursuant to the BioLife Solutions 2013 Performance Incentive Plan (the "Plan") and vests 25% on the first anniversary of the grant date and thereafter quarterly, in 12 equal quarterly installments. The restricted stock was granted to the reporting person as part of 2021 compensation.

Read SEC document
February 05, 2021 Filed Feb 9, 2021 02:14 UTC SaleCommon Stock 40,000 $40.90 $1,636,000.00
Disclosure

SEC source: 0001437749-21-002264 · rdgdoc.xml · nonDerivative · entry 2

VILLIGER WALTER · CIK 0001113655 · 10% owner

WAVI Holding AG · CIK 0001603260 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By WAVI Holding AG

Disclosed balance after: 3,281,778

F1 · ownership.nature: The shares of common stock are held directly by WAVI Holding AG, which is an entity wholly owned and controlled by Walter Villiger.

Read SEC document
February 04, 2021 Filed Feb 9, 2021 02:14 UTC
Mathew Aby J.Exec VP & Chief Scientific Off
Exercise / conversionEmployee Stock Option · Derivative 18,483 $0.00 Strike: $1.12 $0.00
Disclosure

SEC source: 0001437749-21-002263 · rdgdoc.xml · derivative · entry 3

Mathew Aby J. · CIK 0001556355 · Exec VP & Chief Scientific Off

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 18,483 shares

Expires 2021-02-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The employee stock option vested in four equal annual installments commencing on 02/11/2012.

Read SEC document
February 04, 2021 Filed Feb 9, 2021 02:14 UTC
Mathew Aby J.Exec VP & Chief Scientific Off
SaleCommon Stock 18,483 $40.02 $739,689.66
Disclosure

SEC source: 0001437749-21-002263 · rdgdoc.xml · nonDerivative · entry 2

Mathew Aby J. · CIK 0001556355 · Exec VP & Chief Scientific Off

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 180,422

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of November 12, 2020.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.74 to $40.62, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
February 04, 2021 Filed Feb 9, 2021 02:14 UTC
Mathew Aby J.Exec VP & Chief Scientific Off
Exercise / conversionCommon Stock 18,483 $1.12 $20,719.44
Disclosure

SEC source: 0001437749-21-002263 · rdgdoc.xml · nonDerivative · entry 1

Mathew Aby J. · CIK 0001556355 · Exec VP & Chief Scientific Off

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 198,905

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 04, 2021 Filed Feb 9, 2021 02:14 UTC SaleCommon Stock 8,538 $40.65 $347,069.70
Disclosure

SEC source: 0001437749-21-002264 · rdgdoc.xml · nonDerivative · entry 1

VILLIGER WALTER · CIK 0001113655 · 10% owner

WAVI Holding AG · CIK 0001603260 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By WAVI Holding AG

Disclosed balance after: 3,321,778

F1 · ownership.nature: The shares of common stock are held directly by WAVI Holding AG, which is an entity wholly owned and controlled by Walter Villiger.

Read SEC document
February 02, 2021 Filed Feb 4, 2021 01:01 UTC
Mathew Aby J.Exec VP & Chief Scientific Off
Exercise / conversionEmployee Stock Option · Derivative 18,484 $0.00 Strike: $1.12 $0.00
Disclosure

SEC source: 0001437749-21-001915 · rdgdoc.xml · derivative · entry 6

Mathew Aby J. · CIK 0001556355 · Exec VP & Chief Scientific Off

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,483

Underlying: Common Stock · 18,484 shares

Expires 2021-02-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The employee stock option vested in four equal annual installments commencing on 02/11/2012.

Read SEC document
February 02, 2021 Filed Feb 4, 2021 01:01 UTC
Mathew Aby J.Exec VP & Chief Scientific Off
SaleCommon Stock 18,484 $40.23 $743,611.32
Disclosure

SEC source: 0001437749-21-001915 · rdgdoc.xml · nonDerivative · entry 4

Mathew Aby J. · CIK 0001556355 · Exec VP & Chief Scientific Off

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 180,422

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of November 12, 2020.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.25 to $40.83 inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
February 02, 2021 Filed Feb 4, 2021 01:01 UTC
Mathew Aby J.Exec VP & Chief Scientific Off
Exercise / conversionCommon Stock 18,484 $1.12 $20,720.56
Disclosure

SEC source: 0001437749-21-001915 · rdgdoc.xml · nonDerivative · entry 3

Mathew Aby J. · CIK 0001556355 · Exec VP & Chief Scientific Off

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 198,906

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 01, 2021 Filed Feb 4, 2021 01:01 UTC
Mathew Aby J.Exec VP & Chief Scientific Off
Exercise / conversionEmployee Stock Option · Derivative 18,484 $0.00 Strike: $1.12 $0.00
Disclosure

SEC source: 0001437749-21-001915 · rdgdoc.xml · derivative · entry 5

Mathew Aby J. · CIK 0001556355 · Exec VP & Chief Scientific Off

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,967

Underlying: Common Stock · 18,484 shares

Expires 2021-02-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The employee stock option vested in four equal annual installments commencing on 02/11/2012.

Read SEC document
February 01, 2021 Filed Feb 4, 2021 01:01 UTC
Mathew Aby J.Exec VP & Chief Scientific Off
SaleCommon Stock 18,484 $38.71 $715,515.64
Disclosure

SEC source: 0001437749-21-001915 · rdgdoc.xml · nonDerivative · entry 2

Mathew Aby J. · CIK 0001556355 · Exec VP & Chief Scientific Off

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 180,422

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of November 12, 2020.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.50 to $39.70, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
February 01, 2021 Filed Feb 4, 2021 01:01 UTC
Mathew Aby J.Exec VP & Chief Scientific Off
Exercise / conversionCommon Stock 18,484 $1.12 $20,720.56
Disclosure

SEC source: 0001437749-21-001915 · rdgdoc.xml · nonDerivative · entry 1

Mathew Aby J. · CIK 0001556355 · Exec VP & Chief Scientific Off

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 198,906

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 25, 2021 Filed Jan 27, 2021 01:00 UTC SaleCommon Stock 50,000 $41.58 $2,079,000.00
Disclosure

SEC source: 0001437749-21-001310 · rdgdoc.xml · nonDerivative · entry 2

VILLIGER WALTER · CIK 0001113655 · 10% owner

WAVI Holding AG · CIK 0001603260 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By WAVI Holding AG

Disclosed balance after: 3,330,316

F1 · ownership.nature: The shares of common stock are held directly by WAVI Holding AG, which is an entity wholly owned and controlled by Walter Villiger.

Read SEC document
January 22, 2021 Filed Jan 27, 2021 01:00 UTC SaleCommon Stock 29,811 $42.48 $1,266,371.28
Disclosure

SEC source: 0001437749-21-001310 · rdgdoc.xml · nonDerivative · entry 1

VILLIGER WALTER · CIK 0001113655 · 10% owner

WAVI Holding AG · CIK 0001603260 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By WAVI Holding AG

Disclosed balance after: 3,380,316

F1 · ownership.nature: The shares of common stock are held directly by WAVI Holding AG, which is an entity wholly owned and controlled by Walter Villiger.

Read SEC document
January 20, 2021 Filed Jan 22, 2021 01:03 UTC SaleCommon Stock 29,182 $41.03 $1,197,337.46
Disclosure

SEC source: 0001437749-21-001039 · rdgdoc.xml · nonDerivative · entry 2

VILLIGER WALTER · CIK 0001113655 · 10% owner

WAVI Holding AG · CIK 0001603260 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By WAVI Holding AG

Disclosed balance after: 3,410,127

F1 · ownership.nature: The shares of common stock are held directly by WAVI Holding AG, which is an entity wholly owned and controlled by Walter Villiger.

Read SEC document
January 19, 2021 Filed Jan 22, 2021 01:03 UTC SaleCommon Stock 40,000 $40.30 $1,612,000.00
Disclosure

SEC source: 0001437749-21-001039 · rdgdoc.xml · nonDerivative · entry 1

VILLIGER WALTER · CIK 0001113655 · 10% owner

WAVI Holding AG · CIK 0001603260 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By WAVI Holding AG

Disclosed balance after: 3,439,309

F1 · ownership.nature: The shares of common stock are held directly by WAVI Holding AG, which is an entity wholly owned and controlled by Walter Villiger.

Read SEC document
January 15, 2021 Filed Jan 20, 2021 01:00 UTC SaleCommon Stock 29,338 $40.62 $1,191,709.56
Disclosure

SEC source: 0001437749-21-000907 · rdgdoc.xml · nonDerivative · entry 2

VILLIGER WALTER · CIK 0001113655 · 10% owner

WAVI Holding AG · CIK 0001603260 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By WAVI Holding AG

Disclosed balance after: 3,479,309

F1 · ownership.nature: The shares of common stock are held directly by WAVI Holding AG, which is an entity wholly owned and controlled by Walter Villiger.

Read SEC document
January 14, 2021 Filed Jan 20, 2021 01:00 UTC SaleCommon Stock 22,152 $43.08 $954,308.16
Disclosure

SEC source: 0001437749-21-000907 · rdgdoc.xml · nonDerivative · entry 1

VILLIGER WALTER · CIK 0001113655 · 10% owner

WAVI Holding AG · CIK 0001603260 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By WAVI Holding AG

Disclosed balance after: 3,508,647

F1 · ownership.nature: The shares of common stock are held directly by WAVI Holding AG, which is an entity wholly owned and controlled by Walter Villiger.

Read SEC document
January 12, 2021 Filed Jan 14, 2021 01:02 UTC SaleCommon Stock 8,435 $40.40 $340,774.00
Disclosure

SEC source: 0001437749-21-000682 · rdgdoc.xml · nonDerivative · entry 4

VILLIGER WALTER · CIK 0001113655 · 10% owner

WAVI Holding AG · CIK 0001603260 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By WAVI Holding AG

Disclosed balance after: 3,530,799

F1 · ownership.nature: The shares of common stock are held directly by WAVI Holding AG, which is an entity wholly owned and controlled by Walter Villiger.

Read SEC document
January 12, 2021 Filed Feb 17, 2021 01:01 UTC
Schulz MarcusChief Revenue Officer
SaleCommon Stock 2,000 $41.01 $82,020.00
Disclosure

SEC source: 0001437749-21-003035 · rdgdoc.xml · nonDerivative · entry 1

Schulz Marcus · CIK 0001812702 · Chief Revenue Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,107

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of November 12, 2020.

Read SEC document
January 11, 2021 Filed Jan 14, 2021 01:02 UTC SaleCommon Stock 12,723 $40.13 $510,573.99
Disclosure

SEC source: 0001437749-21-000682 · rdgdoc.xml · nonDerivative · entry 3

VILLIGER WALTER · CIK 0001113655 · 10% owner

WAVI Holding AG · CIK 0001603260 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By WAVI Holding AG

Disclosed balance after: 3,539,234

F1 · ownership.nature: The shares of common stock are held directly by WAVI Holding AG, which is an entity wholly owned and controlled by Walter Villiger.

Read SEC document
January 11, 2021 Filed Jan 14, 2021 01:02 UTC SaleCommon Stock 27,277 $40.35 $1,100,626.95
Disclosure

SEC source: 0001437749-21-000682 · rdgdoc.xml · nonDerivative · entry 2

VILLIGER WALTER · CIK 0001113655 · 10% owner

WAVI Holding AG · CIK 0001603260 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By WAVI Holding AG

Disclosed balance after: 3,551,957

F1 · ownership.nature: The shares of common stock are held directly by WAVI Holding AG, which is an entity wholly owned and controlled by Walter Villiger.

Read SEC document
January 11, 2021 Filed Jan 14, 2021 01:02 UTC SaleCommon Stock 40,000 $40.20 $1,608,000.00
Disclosure

SEC source: 0001437749-21-000682 · rdgdoc.xml · nonDerivative · entry 1

VILLIGER WALTER · CIK 0001113655 · 10% owner

WAVI Holding AG · CIK 0001603260 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By WAVI Holding AG

Disclosed balance after: 3,579,234

F1 · ownership.nature: The shares of common stock are held directly by WAVI Holding AG, which is an entity wholly owned and controlled by Walter Villiger.

Read SEC document
January 08, 2021 Filed Jan 14, 2021 01:02 UTC
Schulz MarcusVice President, Global Sales
SaleCommon Stock 293 $39.01 $11,429.93
Disclosure

SEC source: 0001437749-21-000683 · rdgdoc.xml · nonDerivative · entry 1

Schulz Marcus · CIK 0001812702 · Vice President, Global Sales

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,107

F1 · kind: The sale reported herein was made by the issuer to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
January 07, 2021 Filed Jan 9, 2021 01:01 UTC SaleCommon Stock 30,000 $39.55 $1,186,500.00
Disclosure

SEC source: 0001437749-21-000443 · rdgdoc.xml · nonDerivative · entry 3

VILLIGER WALTER · CIK 0001113655 · 10% owner

WAVI Holding AG · CIK 0001603260 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By WAVI Holding AG

Disclosed balance after: 3,619,234

F1 · ownership.nature: The shares of common stock are held directly by WAVI Holding AG, which is an entity wholly owned and controlled by Walter Villiger.

Read SEC document
January 06, 2021 Filed Jan 9, 2021 01:01 UTC SaleCommon Stock 15,075 $41.53 $626,064.75
Disclosure

SEC source: 0001437749-21-000443 · rdgdoc.xml · nonDerivative · entry 2

VILLIGER WALTER · CIK 0001113655 · 10% owner

WAVI Holding AG · CIK 0001603260 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By WAVI Holding AG

Disclosed balance after: 3,649,234

F1 · ownership.nature: The shares of common stock are held directly by WAVI Holding AG, which is an entity wholly owned and controlled by Walter Villiger.

Read SEC document
January 05, 2021 Filed Jan 9, 2021 01:01 UTC SaleCommon Stock 18,948 $42.54 $806,047.92
Disclosure

SEC source: 0001437749-21-000443 · rdgdoc.xml · nonDerivative · entry 1

VILLIGER WALTER · CIK 0001113655 · 10% owner

WAVI Holding AG · CIK 0001603260 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By WAVI Holding AG

Disclosed balance after: 3,664,309

F1 · ownership.nature: The shares of common stock are held directly by WAVI Holding AG, which is an entity wholly owned and controlled by Walter Villiger.

Read SEC document
December 01, 2020 Filed Dec 4, 2020 01:31 UTC
Mathew Aby J.Exec VP & Chief Scientific Off
SaleCommon Stock 380 $35.49 $13,486.20
Disclosure

SEC source: 0001437749-20-024808 · rdgdoc.xml · nonDerivative · entry 1

Mathew Aby J. · CIK 0001556355 · Exec VP & Chief Scientific Off

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 180,422

F1 · kind: The sale reported herein was made by the issuer to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
December 01, 2020 Filed Dec 4, 2020 01:31 UTC
Foster Karen A.Chief Quality Officer
SaleCommon Stock 166 $35.49 $5,891.34
Disclosure

SEC source: 0001437749-20-024807 · rdgdoc.xml · nonDerivative · entry 1

Foster Karen A. · CIK 0001683151 · Chief Quality Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,742

F1 · kind: The sale reported herein was made by the issuer to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
December 01, 2020 Filed Dec 4, 2020 01:30 UTC
Rice MichaelDirector · President & CEO
SaleCommon Stock 813 $35.49 $28,853.37
Disclosure

SEC source: 0001437749-20-024806 · rdgdoc.xml · nonDerivative · entry 1

Rice Michael · CIK 0001389512 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 202,843

F1 · kind: The sale reported herein was made by the issuer to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
November 24, 2020 Filed Nov 27, 2020 22:23 UTC
Casdin Eli10% owner
PurchaseCommon Stock, par value $.001 per share 1,600,000 $22.50 $36,000,000.00
Disclosure

SEC source: 0000919574-20-007362 · ownership.xml · nonDerivative · entry 1

Casdin Partners Master Fund, L.P. · CIK 0001534265 · 10% owner

Casdin Capital, LLC · CIK 0001534261 · 10% owner

Casdin Partners GP, LLC · CIK 0001534260 · 10% owner

Casdin Eli · CIK 0001534264 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,440,107

F1 · kind: The reported securities will be purchased by Casdin Partners Master Fund, L.P. (the "Master Fund") in a private transaction (the "Transaction"). As of November 24, 2020, all material conditions precedent to closing the Transaction have been satisfied.

F2 · ownership.direct: The securities are owned directly by the Master Fund and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC, the investment adviser to the Master Fund, (ii) Casdin Partners GP, LLC, the general partner of the Master Fund, and (ii) Eli Casdin, the managing member of Casdin Capital, LLC and Casdin Partners GP, LLC.

Read SEC document
November 24, 2020 Filed Dec 1, 2020 00:49 UTC SaleCommon Stock 1,600,000 $22.50 $36,000,000.00
Disclosure

SEC source: 0001437749-20-024588 · rdgdoc.xml · nonDerivative · entry 1

GIRSCHWEILER THOMAS · CIK 0001273547 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Taurus4757 GmbH

Disclosed balance after: 47,774

F1 · kind: The reported securities were sold to Casdin Partners Master Fund, L.P. in a private transaction (the "Transaction"). As of November 24, 2020, all material conditions precedent to closing the Transaction have been satisfied.

F2 · ownership.nature: The shares of common stock, par value $0.001 per share, are held directly by Taurus457 GmbH an entity wholly owned by Thomas Girschweiler, a director of Biolife Solutions, Inc.

Read SEC document
November 19, 2020 Filed Nov 21, 2020 01:31 UTC SaleCommon Stock 36,848 $33.35 $1,228,880.80
Disclosure

SEC source: 0001437749-20-024297 · rdgdoc.xml · nonDerivative · entry 2

VILLIGER WALTER · CIK 0001113655 · 10% owner

WAVI Holding AG · CIK 0001603260 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By WAVI Holding AG

Disclosed balance after: 3,683,257

F1 · ownership.nature: The shares of common stock are held directly by WAVI Holding AG, which is an entity wholly owned and controlled by Walter Villiger.

Read SEC document
November 18, 2020 Filed Nov 21, 2020 01:31 UTC SaleCommon Stock 40,000 $32.33 $1,293,200.00
Disclosure

SEC source: 0001437749-20-024297 · rdgdoc.xml · nonDerivative · entry 1

VILLIGER WALTER · CIK 0001113655 · 10% owner

WAVI Holding AG · CIK 0001603260 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By WAVI Holding AG

Disclosed balance after: 3,720,105

F1 · ownership.nature: The shares of common stock are held directly by WAVI Holding AG, which is an entity wholly owned and controlled by Walter Villiger.

Read SEC document
November 17, 2020 Filed Nov 19, 2020 01:30 UTC SaleCommon Stock 40,000 $31.31 $1,252,400.00
Disclosure

SEC source: 0001437749-20-024182 · rdgdoc.xml · nonDerivative · entry 2

VILLIGER WALTER · CIK 0001113655 · 10% owner

WAVI Holding AG · CIK 0001603260 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By WAVI Holding AG

Disclosed balance after: 3,760,105

F1 · ownership.nature: The shares of common stock are held directly by WAVI Holding AG, which is an entity wholly owned and controlled by Walter Villiger.

Read SEC document
November 16, 2020 Filed Nov 17, 2020 02:21 UTC
Rice MichaelDirector · President & CEO
Exercise / conversionEmployee Stock Option · Derivative 11,461 $0.00 Strike: $1.64 $0.00
Disclosure

SEC source: 0001437749-20-024045 · rdgdoc.xml · derivative · entry 9

Rice Michael · CIK 0001389512 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 194,843

Underlying: Common Stock · 11,461 shares

Expires 2021-12-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The option vested in two equal annual installments based on the registrant's satisfaction of certain performance criteria for the fiscal year ending December 2017. The performance criteria for 2017 were met, resulting in vesting of the option as follows: 114,613 shares vested on March 8, 2018 and 114,613 shares vested on March 8, 2019.

Read SEC document
November 16, 2020 Filed Nov 17, 2020 02:21 UTC
Rice MichaelDirector · President & CEO
SaleCommon Stock 11,461 $31.20 $357,583.20
Disclosure

SEC source: 0001437749-20-024045 · rdgdoc.xml · nonDerivative · entry 6

Rice Michael · CIK 0001389512 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 203,656

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.71 to $31.80, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
November 16, 2020 Filed Nov 17, 2020 02:21 UTC
Rice MichaelDirector · President & CEO
Exercise / conversionCommon Stock 11,461 $1.64 $18,796.04
Disclosure

SEC source: 0001437749-20-024045 · rdgdoc.xml · nonDerivative · entry 5

Rice Michael · CIK 0001389512 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 215,117

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 16, 2020 Filed Nov 17, 2020 02:21 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $1.76 $0.00
Disclosure

SEC source: 0001437749-20-024044 · rdgdoc.xml · derivative · entry 9

DE GREEF RODERICK · CIK 0001241181 · CFO & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,000 shares

Expires 2026-03-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The options vested 25% on March 4, 2017 and thereafter, in 36 equal monthly installments.

Read SEC document
November 16, 2020 Filed Nov 17, 2020 02:21 UTC SaleCommon Stock 10,000 $31.33 $313,300.00
Disclosure

SEC source: 0001437749-20-024044 · rdgdoc.xml · nonDerivative · entry 6

DE GREEF RODERICK · CIK 0001241181 · CFO & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 156,293

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.75 to $31.90, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
November 16, 2020 Filed Nov 17, 2020 02:21 UTC Exercise / conversionCommon Stock 10,000 $1.76 $17,600.00
Disclosure

SEC source: 0001437749-20-024044 · rdgdoc.xml · nonDerivative · entry 5

DE GREEF RODERICK · CIK 0001241181 · CFO & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 166,293

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 16, 2020 Filed Nov 19, 2020 01:30 UTC SaleCommon Stock 36,957 $31.68 $1,170,797.76
Disclosure

SEC source: 0001437749-20-024182 · rdgdoc.xml · nonDerivative · entry 1

VILLIGER WALTER · CIK 0001113655 · 10% owner

WAVI Holding AG · CIK 0001603260 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By WAVI Holding AG

Disclosed balance after: 3,800,105

F1 · ownership.nature: The shares of common stock are held directly by WAVI Holding AG, which is an entity wholly owned and controlled by Walter Villiger.

Read SEC document
November 13, 2020 Filed Nov 17, 2020 02:23 UTC SaleCommon Stock 48,306 $31.97 $1,544,342.82
Disclosure

SEC source: 0001437749-20-024050 · rdgdoc.xml · nonDerivative · entry 2

VILLIGER WALTER · CIK 0001113655 · 10% owner

WAVI Holding AG · CIK 0001603260 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By WAVI Holding AG

Disclosed balance after: 3,837,062

F1 · ownership.nature: The shares of common stock are held directly by WAVI Holding AG, which is an entity wholly owned and controlled by Walter Villiger.

Read SEC document
November 13, 2020 Filed Nov 17, 2020 02:23 UTC
Berard ToddChief Marketing Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 5,000 $0.00 Strike: $2.06 $0.00
Disclosure

SEC source: 0001437749-20-024049 · rdgdoc.xml · derivative · entry 6

Berard Todd · CIK 0001633186 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 5,000 shares

Expires 2025-05-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Exercisable to the extent of 1/4th thereof on 05/04/2016, and remaining balance exercisable to the extent of 1/36th thereof on the 4th day of each month commencing on 06/04/2016.

Read SEC document
November 13, 2020 Filed Nov 17, 2020 02:23 UTC
Berard ToddChief Marketing Officer
SaleCommon Stock 5,000 $32.16 $160,800.00
Disclosure

SEC source: 0001437749-20-024049 · rdgdoc.xml · nonDerivative · entry 4

Berard Todd · CIK 0001633186 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,878

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.78 to $32.30, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.